Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research | Zendy

Julie A. Lynch | Zendy; Muin J. Khoury | Zendy; Ann M. Borzecki | Zendy; Jerry Cromwell | Zendy; Laura L. Hayman | Zendy; Pat Reid Ponte | Zendy; Glenn A. Miller | Zendy; Christopher S. Lathan | Zendy

Open Access

Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research

Author(s) -

Julie A. Lynch,

Muin J. Khoury,

Ann M. Borzecki,

Jerry Cromwell,

Laura L. Hayman,

Pat Reid Ponte,

Glenn A. Miller,

Christopher S. Lathan

Publication year - 2013

Publication title -

genetics in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.509

H-Index - 128

eISSN - 1530-0366

pISSN - 1098-3600

DOI - 10.1038/gim.2013.5

Subject(s) - odds ratio , medicine , confidence interval , odds , population , epidermal growth factor receptor , oncology , cancer , logistic regression , environmental health

We examined hospital use of the epidermal growth factor receptor assay in patients with lung cancer in the United States. Our goal was to inform the development of a model to predict phase 3 translation of guideline-directed molecular diagnostic tests.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research